DE122005000029I2 - Synergistische kombinationen von Zidovudine, 1592u89 und 3TC - Google Patents

Synergistische kombinationen von Zidovudine, 1592u89 und 3TC

Info

Publication number: DE122005000029I2
Authority: DE; Germany
Prior art keywords: zidovudine; synergistic combinations; synergistic; combinations
Prior art date: 1995-03-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

DE1996622386

Other languages

English (en)

Other versions

DE69622386T2 (de

DE69622386D1 (de

Inventor

Walter Barry

Clair Heider St

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wellcome Foundation Ltd

Original Assignee

Wellcome Foundation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

1996-03-28

Publication date

2006-04-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122005000029(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-30 Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en

1995-03-30 Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en

1996-03-28 Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd

2006-04-27 Publication of DE122005000029I2 publication Critical patent/DE122005000029I2/de

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Virology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Cephalosporin Compounds (AREA)
Medicinal Preparation (AREA)
Orthopedics, Nursing, And Contraception (AREA)

DE1996622386 1995-03-30 1996-03-28 Synergistische kombinationen von Zidovudine, 1592u89 und 3TC Active DE122005000029I2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9506490.3A GB9506490D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
GBGB9506489.5A GB9506489D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en)	1995-03-30	1996-03-28	Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (1)

Publication Number	Publication Date
DE122005000029I2 true DE122005000029I2 (de)	2006-04-27

Family

ID=26306774

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE200512000029 Pending DE122005000029I1 (de)	1995-03-30	1996-03-28	Synergistische Kombinationen von Zidovudine, 1592u89 und 3tc.
DE69622386T Expired - Lifetime DE69622386T2 (de)	1995-03-30	1996-03-28	Synergistische kombinationen von zidovudine, 1592u89 und 3tc
DE1996622386 Active DE122005000029I2 (de)	1995-03-30	1996-03-28	Synergistische kombinationen von Zidovudine, 1592u89 und 3TC

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DE200512000029 Pending DE122005000029I1 (de)	1995-03-30	1996-03-28	Synergistische Kombinationen von Zidovudine, 1592u89 und 3tc.
DE69622386T Expired - Lifetime DE69622386T2 (de)	1995-03-30	1996-03-28	Synergistische kombinationen von zidovudine, 1592u89 und 3tc

Country Status (35)

Country	Link
US (1)	US6417191B1 (de)
EP (1)	EP0817637B1 (de)
JP (1)	JP2954357B2 (de)
KR (1)	KR100542536B1 (de)
CN (1)	CN1103593C (de)
AP (1)	AP652A (de)
AT (1)	ATE220551T1 (de)
AU (1)	AU715213B2 (de)
BR (3)	BRPI9607851B8 (de)
CA (1)	CA2216634C (de)
CZ (1)	CZ295940B6 (de)
DE (3)	DE122005000029I1 (de)
DK (1)	DK0817637T3 (de)
EA (1)	EA000626B3 (de)
EE (1)	EE04047B1 (de)
ES (1)	ES2179193T3 (de)
FR (1)	FR05C0022I2 (de)
GE (1)	GEP20022647B (de)
HU (1)	HU224010B1 (de)
IL (1)	IL117727A (de)
LU (1)	LU91171I2 (de)
MX (1)	MX9707316A (de)
MY (1)	MY115461A (de)
NL (1)	NL300195I2 (de)
NO (2)	NO313787B1 (de)
NZ (1)	NZ306419A (de)
OA (1)	OA10616A (de)
PL (1)	PL187085B1 (de)
PT (1)	PT817637E (de)
RO (1)	RO117995B1 (de)
SI (1)	SI0817637T1 (de)
SK (1)	SK283825B6 (de)
TR (1)	TR199701074T1 (de)
UA (1)	UA60293C2 (de)
WO (1)	WO1996030025A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2258956A1 (en) *	1996-06-25	1997-12-31	Glaxo Group Limited	Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
AU769660B2 (en) *	1997-05-17	2004-01-29	Glaxo Group Limited	Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
BR9809127A (pt) *	1997-05-17	2000-08-01	Glaxo Group Ltd	Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
WO1999060988A2 (en) *	1998-05-29	1999-12-02	University Of Florida	Combination therapy for treatment of fiv infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US6432966B2 (en)	1999-10-29	2002-08-13	Smithkline Beecham Corporation	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) *	2001-05-11	2011-03-24	Cipla Medpro Pty Ltd	Pharmaceutical composition.
AR040242A1 (es) *	2002-06-04	2005-03-23	Glaxo Group Ltd	Composiciones farmaceuticas
KR20080032014A (ko)	2003-01-14	2008-04-11	길리애드 사이언시즈, 인코포레이티드	복합 항바이러스 치료를 위한 조성물 및 방법
CN100469769C (zh)	2003-03-24	2009-03-18	弗·哈夫曼-拉罗切有限公司	作为逆转录酶抑制剂的苄基-哒嗪酮
US20070202119A1 (en)	2003-10-24	2007-08-30	Ashdown Martin L	Method Of Therapy
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
AU2006303368B2 (en)	2005-10-19	2011-05-26	F. Hoffmann-La Roche Ag	Non-Nucleoside Reverse Transcriptase Inhibitors
ES2550152T3 (es)	2006-12-13	2015-11-04	F. Hoffmann-La Roche Ag	Derivados de 2-(piperidin-4-il)-4-fenoxi-o fenilamino-pirimidina como inhibidores no nucleósidos de transcriptasa inversa
WO2008095263A1 (en) *	2007-02-09	2008-08-14	Alphapharm Pty Ltd	A dosage form containing two or more active pharmaceutical ingredients in different physical forms
HUE026456T2 (en)	2009-05-27	2016-05-30	Biotempus Ltd	Methods of treating diseases
LT3494972T (lt)	2010-01-27	2024-03-12	Viiv Healthcare Company	Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti
HK1220390A1 (zh)	2013-08-29	2017-05-05	Teva Pharmaceutical Industries Ltd.	包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
EP3129009A1 (de)	2014-04-08	2017-02-15	Teva Pharmaceutical Industries Ltd	Einheitsdosisform mit emtricitabin, tenofovir, darunavir und ritonavir
EP3180349B1 (de)	2014-08-12	2025-03-12	Monash University	Lymphenleitungsprodrugs und deren therapeutischen verwendungen
CN108137482B (zh)	2015-09-08	2024-03-15	莫纳什大学	定向淋巴的前药
EP3675838A4 (de)	2017-08-29	2021-04-21	PureTech LYT, Inc.	An das lymphatische system gerichtete lipidprodrugs
US11883497B2 (en)	2017-08-29	2024-01-30	Puretech Lyt, Inc.	Lymphatic system-directing lipid prodrugs
US11304954B2 (en)	2017-12-19	2022-04-19	Puretech Lyt, Inc.	Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en)	2017-12-19	2023-03-21	Puretech Lyt, Inc.	Lipid prodrugs of rapamycin and its analogs and uses thereof
WO2021159021A1 (en)	2020-02-05	2021-08-12	Puretech Lyt, Inc.	Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
US5047407A (en)	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en)	1988-06-10	1992-06-16	Regents Of The University Of Minnesota	Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
US5204466A (en)	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en)	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9104740D0 (en) *	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
WO1992020344A1 (en)	1991-05-16	1992-11-26	Glaxo Group Limited	Antiviral combinations containing nucleoside analogs
AU4079593A (en)	1992-05-13	1993-12-13	Wellcome Foundation Limited, The	Therapeutic combinations
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en)	1994-08-26	1994-10-19	Wellcome Found	A novel salt
US5869461A (en)	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
EA001457B1 (ru)	1996-06-25	2001-04-23	Глаксо Груп Лимитед	Комбинации, содержащие vx478, зидовудин и/или 1592u89, для применения при лечении вич
CA2258956A1 (en)	1996-06-25	1997-12-31	Glaxo Group Limited	Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
DE10226522A1 (de)	2002-06-14	2003-12-24	Degussa	Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 EA EA199700203A patent/EA000626B3/ru not_active IP Right Cessation
- 1996-03-28 UA UA97094740A patent/UA60293C2/uk unknown
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 CA CA002216634A patent/CA2216634C/en not_active Expired - Lifetime
- 1996-03-28 SK SK1295-97A patent/SK283825B6/sk not_active IP Right Cessation
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/en not_active Ceased
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 MX MX9707316A patent/MX9707316A/es active IP Right Grant
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/ko not_active Expired - Lifetime
- 1996-03-28 EE EE9700240A patent/EE04047B1/xx not_active IP Right Cessation
- 1996-03-28 AT AT96911953T patent/ATE220551T1/de active
- 1996-03-28 JP JP8528931A patent/JP2954357B2/ja not_active Expired - Lifetime
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/xx unknown
- 1996-03-28 PT PT96911953T patent/PT817637E/pt unknown
- 1996-03-28 PL PL96322532A patent/PL187085B1/pl unknown
- 1996-03-28 CN CN96194050A patent/CN1103593C/zh not_active Expired - Lifetime
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/pt unknown
- 1996-03-28 DK DK96911953T patent/DK0817637T3/da active
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 NZ NZ306419A patent/NZ306419A/xx not_active IP Right Cessation
- 1996-03-28 RO RO97-01795A patent/RO117995B1/ro unknown
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/de active Pending
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/cs not_active IP Right Cessation
- 1996-03-28 ES ES96911953T patent/ES2179193T3/es not_active Expired - Lifetime
- 1996-03-28 SI SI9630494T patent/SI0817637T1/xx unknown
- 1996-03-28 DE DE69622386T patent/DE69622386T2/de not_active Expired - Lifetime
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/pt not_active IP Right Cessation
- 1996-03-28 HU HU9801571A patent/HU224010B1/hu active Protection Beyond IP Right Term
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/de active Active
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/pt active IP Right Grant
- 1996-03-28 EP EP96911953A patent/EP0817637B1/de not_active Expired - Lifetime
- 1996-03-29 IL IL11772796A patent/IL117727A/xx not_active IP Right Cessation
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/no not_active IP Right Cessation
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/fr unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-09 NL NL300195C patent/NL300195I2/nl unknown
- 2005-05-24 NO NO2005014C patent/NO2005014I2/no unknown

Also Published As

Publication number	Publication date
UA60293C2 (uk)	2003-10-15
AP652A (en)	1998-06-19
DE69622386T2 (de)	2003-02-13
FR05C0022I2 (de)	2005-10-21
EA199700203A1 (ru)	1998-02-26
BRPI9607851B8 (pt)	2019-11-05
JP2954357B2 (ja)	1999-09-27
SK283825B6 (sk)	2004-02-03
KR100542536B1 (ko)	2006-03-23
BRPI9612992B1 (pt)	2020-08-04
PL322532A1 (en)	1998-02-02
IL117727A (en)	1999-11-30
ATE220551T1 (de)	2002-08-15
NL300195I1 (nl)	2005-08-01
TR199701074T1 (xx)	1998-02-21
NO974510D0 (no)	1997-09-29
JPH10511682A (ja)	1998-11-10
RO117995B1 (ro)	2002-12-30
SI0817637T1 (en)	2002-10-31
NZ306419A (en)	2000-01-28
PT817637E (pt)	2002-11-29
NO313787B1 (no)	2002-12-02
AU5497296A (en)	1996-10-16
BR9607851A (pt)	1998-07-21
NO2005014I2 (no)	2008-02-11
EA000626B3 (ru)	2016-04-29
DK0817637T3 (da)	2002-11-11
EP0817637B1 (de)	2002-07-17
BR9607851B1 (pt)	2009-01-13
WO1996030025A1 (en)	1996-10-03
EP0817637A1 (de)	1998-01-14
SK129597A3 (en)	1998-07-08
EE04047B1 (et)	2003-06-16
US6417191B1 (en)	2002-07-09
LU91171I2 (fr)	2005-07-04
FR05C0022I1 (de)	2005-06-10
IL117727A0 (en)	1996-07-23
AP9701089A0 (en)	1997-10-31
GEP20022647B (en)	2002-03-25
MX9707316A (es)	1997-11-29
CN1103593C (zh)	2003-03-26
MY115461A (en)	2003-06-30
HK1009401A1 (en)	1999-09-10
EA000626B1 (ru)	1999-12-29
DE122005000029I1 (de)	2005-10-06
PL187085B1 (pl)	2004-05-31
CA2216634C (en)	2004-07-20
LU91171I9 (de)	2018-12-28
HUP9801571A3 (en)	2001-04-28
CN1185110A (zh)	1998-06-17
ES2179193T3 (es)	2003-01-16
HU224010B1 (hu)	2005-04-28
CA2216634A1 (en)	1996-10-03
OA10616A (en)	2001-03-15
AU715213B2 (en)	2000-01-20
NO974510L (no)	1997-09-29
NL300195I2 (nl)	2005-11-01
DE69622386D1 (de)	2002-08-22
HUP9801571A2 (hu)	1999-01-28
EE9700240A (et)	1998-04-15
NO2005014I1 (no)	2005-06-06
KR19980703420A (ko)	1998-11-05
CZ309097A3 (cs)	1998-05-13
CZ295940B6 (cs)	2005-12-14

Publication	Publication Date	Title
ATE220551T1 (de)	2002-08-15	Synergistische kombinationen von zidovudine, 1592u89 und 3tc
DE69415157D1 (de)	1999-01-21	Elektrochirurgischer prozessor und anwendung
BR9702553A (pt)	1998-09-29	Composição cosmética e utilização
DE69842004D1 (de)	2010-12-30	Substituierte 2-aminoacetamide und anwendung davon
NO954201D0 (no)	1995-10-20	Kosmetikk-blanding
FI964311L (fi)	1996-10-25	Bifunktionaalinen proteiini, valmistus ja käyttö
DE69629987D1 (de)	2003-10-23	Funktelefone und Betriebsverfahren
BR9609831A (pt)	1999-03-09	Composições cosméticas e/ou farmacêuticas antipruríticas
BR9505368A (pt)	1997-10-28	Composição cosmética ou dermatogógico água-em-óleo
PT946566E (pt)	2004-03-31	Formas pro-farmacos e analogos da camptotecina sua aplicacao como medicamentos
DE69634489D1 (de)	2005-04-21	Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
ATE257708T1 (de)	2004-01-15	Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
FI972988A0 (fi)	1997-07-14	Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
DE69624042D1 (de)	2002-11-07	TiO2 dotiertes, Ta2O5 enthaltendes dielektrisches Material und dieses enthaltende Bauteile
FI963334L (fi)	1996-08-27	Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
BR9800753B1 (pt)	2010-10-19	composição cosmética e/ou dermatológica e uso de uma composição.
FI952738L (fi)	1995-07-31	Stabiiliproteiini, fosfolipidikoostumuksia ja menetelmiä
KR960030598U (ko)	1996-10-22	이,미용원용가습장치
ATE228575T1 (de)	2002-12-15	Wirkstoffkombinationen
FI972965L (fi)	1997-07-11	Uusia peptidejä, niiden valmistus ja käyttö
DE59607418D1 (de)	2001-09-06	Haarbehandlungsmittel
FI963720A0 (fi)	1996-09-19	N-aryyli- ja N-alkyylisulfonyyliaminaalit tuholaisten torjunta-aineina
FR2761061B1 (fr)	1999-04-23	Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
KR960033565U (ko)	1996-11-19	지압 및 쑥뜸 겸용 지압구
PT101949A (pt)	1997-06-30	Boneco com elevacao simultania de bracos, pernas e abertura de olhos